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Respiratory disease (shipping fever) in cattle typically occurs 
shortly after transportation of the animals to feedlots. It is 
manifested as a pneumonia #ich often leads to loss of weight and in 
some instances death of the animed. The causative factors involved 
are believed to include viruses (Infectious Bovine RhinotracheitiS/ 
Bovine Respiratory Syncitial Virus, Bovine Viral Diarrhea Virus and/or 
Parainfluenza-3 virus), bacteria (Pasteurella hanolytica, Pasteurella 
multocida and Haemophilus scmnus) and stress-induced increases in 
glucocorticoid levels (1). 
It has long been known that glucocorticoids possess anti­
inflammatory activity and are immunosuppressive. They can adversely 
affect the activity of lyn^ocytes, monocytes and neutrophils (2,3). 
It has previously been reported that in vivo dexamethasone treatment 
in cattle is capable of altering a number of neutrophil functions such 
as suppressing iodination, antibody-dependent cell-mediated 
cytotoxicity (ADCC), oxidative metabolism and enhancing random 
migration (4). Some of the most recent findings suggest that the mode 
of action of glucocorticoids for their anti- inflammatory effects is 
the induction of synthesis of a phospholipase Ag (PLAg) inhibitory 
protein called lipocortin. By inhibiting PLAg, lipocortin effectively 
blocks the release of arachidonic acid from the cells' phospholipids. 
Normally arachidonic acid is released upon stimulation of neutrophils 
and metabolized via the lipoxygenase pathway to end products which can 
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in turn alter neutrophil function (5,6,7). 
There were two primary goals of this research. The first was to 
compare the arachidonic acid metabolian of neutrophils from control 
and dexamethasone-treated cattle and to determine if changes in the 
arachidonic acid metabolism could account for sane or all of the 
alterations of functions seen with dexamethasone treatment. It is 
hoped that this information will give more insight as to what may be 
required to prevent or reverse these effects. This work is reported 
in the section aititied "Relationship of Glucocorticoid Suppression of 
Arachidonic Acid Metabolism to Alteration of Neutrophil Function". 
The second part of this research involved the evaluation of the 
effects of the immunomodulator, tuftsin, on bovine neutrophil 
function. Tuftsin was tested both in vitro and in vivo to determine 
if its use might effectively alter the effects of dexamethasone on 
neutrophil function. The results are reported in the section entitled 
"Evaluation of the in vitro and in vivo effects of tuftsin on normal 
and suppressed bovine neutrophils". 
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LITERATURE REVIEW 
Role and Physiology of the Neutrophil 
Neutrophils are the predominant granulocyte found in mammalian 
blood. A large, multilobed nucleus and neutral staining granules are 
the hallmark characteristics of these cells. Present in the cytoplasm 
are two types of granules known as azurc^hilic (contain numerous 
hydrolytic enzymes as well as myeloperoxidase and lysozyme) and 
specific (contain primarily lysozyme and lactoferrin) granules as well 
as numerous glycogen granules, a few mitochondria and even fewer 
ribosomes and rough or smooth endoplasmic reticulum (8). 
The classic role of the neutrophil has long been defined as that 
of the "first line of defense" of the immune system. This is because 
they are often the first, leukocyte to respond to invading 
microorganisms. They are well suited for this role in that they are 
numerous, extremely motile and thus able to respond quickly to a 
chemotactic gradient, highly phagocytic and are capable of producing a 
number of toxic oxygen radicals as well as releasing microbicidal 
proteins and enzymes. They are the predominant cell type found in the 
early phases of an inflammatory response (9). 
In the past the role of the neutrophil in host defense was 
thought to be rather limited. Seme have considered them little more 
than a bag of enzymes designed to quickly intercept, destroy and 
ramove foreign material. While this is in part true, recent studies 
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suggest that their role in the irnnune response may be more complex 
than was previously appreciated. It has been danonstrated that they 
do synthesize some proteins (10) (a scarcity of ribosomes had led 
others to believe these cells are devoid of protein synthesis (8,11)) 
and that their activities are subject to regulation by various 
lymphokines and monokines (12,13). Studies into the physiology and 
biochemistry of the neutrophil have revealed it to be a quite complex 
secretory cell *Aich has perhaps been underestimated in its ability to 
be regulated. 
There are several properties of neutrophils which enable than to 
carry out their role including: 1) the ability to adhere to blood 
vessel walls and to migrate out of the blood into the body tissues 2) 
the ability to respond to chanoattractants, e.g., ccmplanent or 
bacterial components 3) the ability to generate a number of oxygen 
derivatives including superoxide anion, hygroxyl radicals and hydrogen 
peroxide 4) the ability to phagocytize or aigulf foreign particles 5) 
the ability to degranulate or discharge the contents of their granules 
and 6) the ability to lyse foreign cells by a process known as 
antibody^dependent cell-mediated cytotoxicity (ADCC) (4,8,9). These 
different functional capacities can be evaluated in the laboratory by 
a nunber of tests. For example, random migration under agarose 
measures the neutrophils' ability to migrate outward from a center 
well. 
Phagocytosis may be measured by mixing neutrophils with a 
suspension of radiolabelled opsonized bacteria for a period of time 
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and then determining the amount of radioactivity internalized versus 
the total amount added. The generation of superoxide anion and other 
oxygai radicals is termed the oxidative burst. It can be evaluated by 
several methods such as measuring the reduction of cytochrome C by 
stimulated neutrophils (often superoxide dismutase is also used and 
the results reported as the amount of superoxide dismutase inhibitable 
cytochrome C reduction). Another method involves determining the 
amount of chemiluninescence or the light energy emitted by the 
oxidative burst as detected by a g^otomultiplier tube. Degranulation 
can be determined by directly measuring the amount of a particular 
enzyme found in the granules vAiich is released cpon stimulation or it 
can be measured indirectly by an iodination assay. In this assay the 
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amount of I bound to trichloroacetic acid precipitable protein is 
determined. It is an indirect measure of degranulation because both 
myeloperoxidase, an enzyme from the azurophilic granules, is required 
as well as which is generated by the oxidative burst (13,14,15). 
Numerous studies have been aimed at understanding the sequence of 
events involved \ftien the neutrophil is triggered to undergo 
phagocytosis, enzyme release, etc. Typically, in the body, the 
response is triggered by the binding of antigen-antibody complexes or 
complemait components to the receptors on the cells. Neutrophils have 
receptors for the Fc portion of immunoglobulins as well as for 
canplemait components C5a and C3b (16). They also have receptors for 
the oligopeptide N-formyl-methionyl-leucyl-phenylalanine (EMLP), 
however bovine neutrophils apparently have no EMLP receptors (16,17). 
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While these ligands are often used in experimaital conditions other 
agonists of neutrophil activity are also employed which do not work 
through niennbrane receptors. Calcium ionogAiores, for example, act to 
directly change calcium levels while phorbol esters act by binding 
directly to a protein kinase enzyme (18), By using a variety of these 
stimuli, scientists can dissect some of the initial events which take 
place during neutrophil activation, determine vAich are essential and 
how they in turn lead to other events. 
While we are far from having a complete picture of what takes 
place when these cells are stimulated some events have been well 
studied. The general scheme involves a change in the plasma membrane 
potential, changes in cAMP and calcium levels followed closely by 
superoxide anion production and release of lysosomal enzymes and 
phagocytosis (19). For the sake of convenience the study of the 
triggering process can be divided into 3 categories: 1) determining 
the identity of the second messenger(s) 2) determining v^ich event(s) 
allows the release or generation of the second messenger(s) and 3) 
determining what action the second messenger(s) has on other 
components within the cell, 
Adenosine-3',5'-monophosphate (cAMP) has been found to be a 
second messenger in a number of different cells. An increase in the 
levels of cAMP in neutrophils following stimulation is one of the 
earliest detectable events, which make it an attractive candidate as 
the neutrophil's second messenger. The cAMP concentration rises, 
peaking at about 1 minute following stimulation and returns to basal 
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levels by approximately 5 minutes (20,21). However, the possibility 
of cAMP being the second messenger in neutrophils has been discarded 
for the following reasons: 1) the use of phosphodiesterase inhibitors 
and other substances which increase cAMP levels do not enhance 
neutrophil responses, 2) by using very low concentrations of various 
stimuli, it is possible to obtain transient increments in cAMP levels 
without triggering superoxide anion production or œzyme release and 
3) it was determined that increased cAMP levels are not required for 
degranulation to take place (22). 
Another possible second messenger in neutrogdiils is calcium. 
There is normally a rapid uptake of extracellular calcium after 
stimulation (23). At first it was believed that this influx was 
crucial, until it was discovered that neutrophil responses were . 
diminished but not totally blocked by the use of ethylenediamine 
tetraacetate, therefore an influx of calcium cannot be an absolute 
requiranait, discounting extracellular calcium as the second messenger 
(24). At that time attention was turned to intracellular calcium 
levels. It was found that IMB-S, an inhibitor of intracellular 
calcium; and trifluoperazine and W-7, inhibitors of calmodulin could 
completely block neutrophil responses. It is generally believed that 
increases in cytosolic levels of calcium is one of the second 
messenger(s) in neutrophils and that the plasma membrane is one source 
of this calciun (22,24). 
It has been shown that there is a good relationship between 
phosphatidylinositol turnover and calcium mobilization. A current 
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hypothesis is that a phosphorylated form of jAiosphatidylinositol, 
polyphosphoinositoi (PPI), is responsible for calcium mobilization 
(25). Receptor-ligand binding leads to the breakdown of PPI forming 
inositol-1,4,5-triphosphate (ITP) and diacylglycerides. It was found 
that ITP can induce the release of calcium in pancreatic acinar cells 
from a nonmitochondrial pool. In addition, the diacylglyceride (vdiich 
alone may activate a protein kinase) can be phosphorylated to form 
phosphatidic acid which has ionophoric properties and thus may assist 
in mobilizing calcium (26,27). 
There are several actions vAiich are known to occur due to the 
increase in calcium levels. One of these is the activation of protein 
kinase C. Once activated this enzyme is believed to activate one of 
the components of the nicotinamide adenine dinucleotide phosphate 
oxidase complex which is responsible for the generation of superoxide 
anion and thus initiates the oxidative burst in neutrophils. This 
enzyme complex is an electron transport chain which appears to be 
located in intracellular organelles and is translocated and/or 
activated upon stimulation. The biochemical mechanisms responsible 
for this action are not well understood, but there is evidence that 
the calcium and pbospholipid-dependent protein kinase C plays a 
central role in this response (28,29). 
Another effect of changes in cytoplasmic calcium levels is on the 
neutrophils' cytoskeletal structures. Stimulation of neutrophils has 
been shown to increase the association of actin with the cytoskeleton. 
There are several activities of the cell vAich require actin-myosin 
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interaction including migration, gAiagocytosis and lysosome-phagosome 
fusion. However, it is not increases in calcium levels vAiich cause 
this but instead localized decreases in cytosol calcium concaitration. 
It is possible that the polymerization of actin into microfilaments 
may be initiated by a drop in calcium at the site of calcium release. 
It is known that calciun acts to activate gelsolin which can bring 
about the dissolution of the actin network and serve to terminate the 
cycle (30,31). 
The mobilization of calcium can also lead to the activation of 
phospholipase Ag (PLAg) which can act to cleave arachidonic acid from 
membrane phospholipids (22). The resulting free arachidonic acid can 
then be metabolized via the cyclooxygenase or lipoxygenase pathways in 
neutrophils. Certain prostaglandins (products of the cyclooxygenase 
pathway) have been found to be produced by neutrophils, however the 
predominant metabolites formed are leukotrienes and the 
hydroxyeicosatetraenoic acids (HETEs). Both are products of the 
lipoxygenase pathway. These products are believed to play a role in 
regulating some of the cell's responses and will be discussed in 
detail in the next section (32). 
Arachidonic Acid Metabolites and Their Role in Regulation of 
Neutrophil Activity 
The prostaglandins (PGs) were first discovered in the 1930s when 
Raphael Kurzrok and Charles Lid] reported that a substance(s) in 
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seminal fluid could cause the contraction of smooth muscle tissue. 
This observation was followed up by a number of researchers and by the 
late 1950s prostaglandin Ej^ (PGB^) and PGF^ were obtained in 
crystalline form. Since that time a nunber of different 
prostaglandins have been isolated and studied (33). All have the 20 
carbon chain polyunsaturated fatty acid arachidonic acid as their 
precursor. The arachidonic acid is converted to an unstable 
endoperoxide intermediate PGGg which is subsequently reduced by a 
hydroperoxidase to a second unstable endoperoxidase intermediatey 
PGHg. PGHg breaks down to PGBg and PGDg. In addition, PGHg can be 
converted to prostacyclin, PGIg, or thromboxane, TBAg (34). 
There are many actions attributable to the PGs sane of which are 
exact opposites. Sane PGs contract smooth muscle tissue while others 
relax it; some are potent vasodilators while others are 
vasoconstrictors (35). Their influence on the immune system is often 
quite complex. Many of the prostaglandins are considered to be 
responsible for the cardinal signs of inflammation (redness, heat, 
swelling and pain) In this regard they would be considered pro­
inflammatory molecules and yet in certain instances, e.g., chronic 
inflammation they are found to have a negative regulatory role (36). 
One of the most difficult tasks facing scientists in this area today 
is trying to sort out the sometimes conflicting reports regarding the 
action of PGs on the immune system. A great deal of work is needed to 
conpletely understand the canplex interactions these molecules have on 
the various cells involved in the inrnune response. 
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In the 1970s the structures of a previously unknown family of 
conpounds, which are also derivatives of arachidonic acid, were 
determined. These compounds were not products of the cyclooxygenase 
enzymes but instead were produced by a different set of enzymes which 
make up the lipoxygenase pathway (37,38). These metabolites 
(leukotrienes and HBTEs) are made predominantly by leukocytes but the 
different cells may vary dramatically in vAiich ones they synthesize 
and the amount synthesized. The formation of any of the 
cyclooxygenase and/or lipoxygenase products depends on the deacylation 
of arachidonic acid from cellular phospholipids vAich is catalyzed by 
the action of various phospholipases. The enzyme gAiospholipase A2 is 
considered to be one of the key regulatory enzymes involved in the 
production of arachidonic acid metabolites. This enzyme cleaves the 
second fatty acid from the glycerol backbone of phospholipids which is 
predominantly arachidonic acid (39). 
In the lipoxygenase pathway, arachidonic acid is converted to one 
of the hyaroperoxyeicosatetraenoic acids (HPETEs) which are then 
converted to their monohydroxyeicosatetraenoic forms (HETEs). The 5-
lipoxygenase pathway is of particular interest because it can lead to 
the production of not only 5-HETE, but also the leukotrienes. The 5-
HPETE may be converted to 5-HETE or to an unstable intermediate, 
leukotriene (LTA^J . The LTA^ is converted to LTB^ or LTD^, LTE^ or 
LTF^ by a glutathione transferase enzyme. These products (LTD^, LTE^, 
LTF^) account for the biological activity known as the slow-reacting 
substance of anaphylaxis. These leukotrienes are rapidly metabolized 
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while LTB^ may be oxidized to less biologically active compounds 
through anega-oxidation. As a result, these products are generally 
very short lived (35,40). 
Leukotriene is the primary lipoxygenase product produced by 
neutrophils. It is highly chemotactic (in the nanogram range) with a 
potency equal to that of C5a and ENLP (41), In addition, LTB^ also 
stimulates aggregation of leukocytes, ion fluxes and the expression of 
C3b receptors on polymorphonuclear leukocytes (PMNs) (42,43,44). In 
the presence of cytochalasin B, LTB^ is a weak inducer of 
degranulation and superoxide anion production and it has also been 
found to induce suppressor cell activity in T cells (45,46). Because 
it is chemotactic for eosinophils and enhances the expression of C3b 
receptors on these cells it has been suggested that this molecule is 
the eosinophil chemotactic factor of anaphylaxis (44). 
There are 2 proposed mechanisms of action by which LTB^ may exert 
its effects. Based on experiments using liposomes it was hypothesized 
that LTB^ acts as a calcium ionophore (47). It is associated with an 
influx of calcium ions and it has been suggested that LTB^ may be an 
intracellular calciun ionophore thus regulating calcium fluxes in 
different parts of the cell. However, Goldman and Goetzl (48) found 
that there exist receptors for LTB^ on PMNs. In addition, they and 
Lin et al. (49,50) discovered that there are in fact 2 types of 
receptors, low and high affinity. Since only a very small amount of 
LTB^ is required to stimulate neutrophil chamotaxis and aggregation 
while much larger amounts of LTB^ are required to induce degranulation 
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it may be that binding to the different receptors results in different 
activities. The presence of these receptors implies that LTB^ works 
through receptors; however, LTB^ may also work within the cells which 
produce it by regulating calcium levels as suggested by Serhan et al. 
(47). 
The HETEs have also been shown to be chemotactic although not to 
the same extent as LTB^ (51). In addition, 5-HETE has been found to 
have a potentiating effect on granulocyte degranulation (52). Stenson 
and Parker (53) demonstrated that after being formed, 5-HETE is 
reincorporated into the phospholipids of the membranes. They suggest 
that this may result in an alteration of the fluidity of the membrane 
allowing for better phagosome-lysosome fusion. 
Immunosuppressive Effects of Glucocorticoids on Neutrophils and Their 
, Mechanisms of Action 
Physical and/or psychological stress normally results in an 
increase in the blood levels of the glucocorticoid hormones Cortisol 
or corticosterone in animals (54,55). Increased glucocorticoid levels 
may also occur when certain synthetic steroids (prednisolone, 
dexamethasone) are used as part of medical treatment. Examples in 
bovine medicine where synthetic glucocorticoids may be used include 
the treatment of ketosis, mastitis, respiratory tract disease, udder 
edema, inflanrtiatory musculo-skeletal conditions and for induction of 
parturition (56,57). Stress-induced increases in glucocorticoid 
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levels is also believed to play a significant role in the development 
of shipping fever in cattle (58). Whether the changes occur naturally 
or are therapeutically induced, increased glucocorticoid levels have a 
profound suppressive effect on the cells of the immune system. In 
general, they cause a decrease in inflammatory reactions and a 
suppression of both cellular and hunoral immune responses (2,4). 
While this immunosuppressive or anti-inflammatory action of 
glucocorticoids has long been known, it has only been in recent years 
that progress has been made in understanding the mechanism of action 
of glucocorticoids on the immune system. 
When reviewing the literature on the actions of glucocorticoids 
on the immune response there are a number of factors which should be 
kept in mind, such as the animal model used, type and form of drug 
used, route of administering the drug, and length of incubation time 
when used in vitro. It is often pointed out in the literature that 
there are steroid sensitive (rats, mice rabbits) and steroid resistant 
(humans, guinea pigs, cattle) species (59,60), This distinction has 
been made based primarily on the survival of blood lymphocytes or 
thymocytes from these various species in the presence of 
glucocorticoids either in vivo or in vitro. The steroid sensitive 
species are said to have a more profound, longer lasting response to 
steroid treatment. This difference raises sane obvious questions as 
to whether the mechanism of action of the steroids may be different in 
different species. However, Cohen and Crnic (61) question whether 
such differences really exist. In a recent review they point out that 
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in many of the studies comparing the responses of different species 
such factors as form of drug used (long versus short acting), and 
dosage used (comparison on a per kilogram basis may not always be 
proper) are not given much consideration. For example, Cortisol is 
the predominant glucocorticoid in human plasma while corticosterone is 
the predominant one found in mice. Therefore, is it valid to directly 
compare the effects of hydrocortisone in humans versus mice, and if 
so, in #at concentration? In addition, the short acting derivatives 
(succinates) of synthetic glucocorticoids are used in in vivo human 
studies while in mice most studies involve the use of Cortisol 
acetate, an insoluble depot-effect form. Cohen and Crnic (61) 
conclude that whenever an adequate basis for comparison exists there 
is little difference between the supposed steroid resistant and 
sensitive species. 
Another consideration one must take into account is that in vitro 
and in vivo effects of glucocorticoids have often been found not to 
correlate well. Some researchers have found that in order to mimic 
the in vivo responses of glucocorticoids in vitro it was necessary to 
use dosages far beyond those found in the animal (60,62). Obviously, 
under such conditions it is difficult if not impossible to determine 
if the same mechanism is responsible for the in vivo and in vitro 
actions. 
Based on this information it is clear that one must exercise 
caution in interpreting the effects of glucocorticoids on the immune 
system. It is necessary to consider the conditions under which the 
16 
data were gathered and whether the findings can be duplicated in other 
models. The following is a general sunmary of the effects of 
glucocorticoids on neutrophil functions which appear to hold true in 
several different species when a variety of different glucocorticoids 
are used. 
Effects of glucocorticoids on neutrophils 
There is a great deal of literature concerning the suppressive 
effects of glucocorticoids on neutrophils. When one considers that 
neutrophils are the primary cell type found in an early inflammatory 
response and that steroid treatment is often used to suppress 
inflanmmation, it is not surprising to find most neutrophil functions 
evaluated are altered by glucocorticoids. 
Perhaps the most obvious change accompanying glucocorticoid 
treatment is a dramatic neutrophilia. A 5 fold increase in the number 
of circulating neutrophils can be seen 24 hours following a single 
intramuscular injection of dexamethasone in cattle (63). Others have 
reported similar results in humans using a variety of glucocorticoids 
(64,65). This neutrophilia is thought to be due to an increased 
efflux of cells from the bone marrow as well as a decrease in the 
number of marginated neutrophils. In cattle this increase is seen 
without a significant increase in the number of banded or immature 
forms (63). 
Another property of neutrophils which is changed with 
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glucocorticoid treatment is random migration (4,66). In cattle, 
treatment with pharmacological doses of dexamethasone gives a dramatic 
enhancement of random migration (4). A reduction in the neutrophil's 
ability to adhere to blood vessel walls as well as a decrease in its 
ability to respond to chemoattractants is probably one of the primary 
reasons vAiy glucocorticoid treatment acts to reduce the infiltration 
of these cells into the inflammatory site (66). 
Other functions of the bovine neutrophil which are compromised by 
dexamethasone treatment include iodination (an important bactericidal 
mechanism and an indirect measure of degranulation), antibody-
dependent cell-mediated cytotoxicity (ADOC), superoxide anion 
production and degranulation (4). The ADCC response is considered an 
important antiviral and antitumor mechanism (67,68). Some have also 
reported a decrease in phagocytosis by neutrophils from glucocorticoid 
treated animals, however there are a number of conflicting reports in 
the literature regarding this and in cattle the decrease in 
phagocytosis is not a consistent phenomenon (4,69,70,71,72,73). 
The effects of glucocorticoids on monocytes of different species 
is similar to its effects on neutrophils (decreased oxidative 
metabolism, cytotoxicity and phagocytosis). While lymphocytes in 
general respond to glucocorticoids by showing a decreased 
proliferative response, decreased antibody production and decreased 
cytotoxic reactions. These effects are discussed further in several 
current reviews (3,61,74). 
18 
Mechanism of action of glucocorticoids on leukocytes 
As mentioned previously, a number of properties of leukocytes 
have been found to be altered by glucocorticoid treatment but exact 
mechanisms of action for many of these functions remain unknown. It 
was previously thought that glucocorticoids act to stabilize the 
membranes. These membrane changes sonehow rendered the lymphocytes 
vulnerable to lysis. A lymphopenia is observed in many animal species 
following glucocorticoid treatment and this was thought to result from 
the lysis of these cells; however, it is now known that the decrease 
in lymphocyte numbers is due to redistribution of the recirculating 
lymphocytes (61,64). Although some lyn#iocytes are lysed by 
pharmacological levels of glucocorticoids, wyilie (75) demonstrated 
that this was due to the production of an endogenous endonuclease 
enzyme. In addition, no stabilization of neutrophil membranes was 
found when the cells were treated in vitro or in vivo with 
glucocorticoids (76). 
Stevenson (77) was one of the first to show that alterations in 
neutrophil function by glucocorticoids may be indirectly mediated. He 
found that increases in neutrophil random migration are possible in 
vitro if the supernatant from hydrocortisone-treated monocytes is 
added to the neutrophils. He gave evidence that a peptide in the 
supernatant was responsible for this action and proposed the 
hypothesis that the peptide was increasing the basal cAMP levels in 
neutrophils, and in this way increasing the randan migration (78). 
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This indirect effect of steroids on neutrophil function may in part 
explain the failure to successfully mimic in vitro the in vivo 
findings. 
Glucocorticoids are capable of inducing increases in cAMP levels 
and are able to work synergistically with other adenyl cyclase 
stimulators to greatly potentiate their actions (79). Although it has 
been speculated that this might be an important mode of action for 
glucocorticoids (66) little work has been done to reveal a direct link 
between changes in cAMP levels and the effects of steroids on 
neutrophils. 
The classical mode of action of steroids on most cells is that 
the steroid binds to a receptor in the cytosol which is then 
translocated to the nucleus resulting in the synthesis of new proteins 
(80). Many leukocytes including neutrophils, lymphocytes, monocytes 
and macrophages have been shown to possess Cortisol receptors (81). 
In the late 1970s, two groups working independently discovered 
that glucocorticoids induce the production of a phospholipase Ag 
inhibitory protein (5,82). As mentioned earlier the phospholipase A^ 
enzyme is a key regulatory enzyne for both the lipoxygenase and 
cyclooxygenase pathways. 
Flower and Blackwell (5) found that perfusion of a guinea pig 
lung with dexamethasone would inhibit the amount of PG recovered in 
the lavage fluid. The addition of exogenous arachidonic acid would 
prevent this action indicating that the steroid vas not working at the 
level of the cyclooxygenase enzyme. In addition, transcription and 
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translation inhibitors would also prevent the dexamethasone effect. 
They interpreted this to be an indication that the dexamethasone was 
working through the classical mode of action of glucocorticoids 
(induction of protein synthesis). It was also found that the potency 
of PG inhibition by different glucocorticoids correlated with their 
capacity to bind to their receptors (5). 
After these initial findings they chose to switch to rat 
peritoneal macrophages to study this phenomenon further (83). The 
results obtained when the macrophages were incubated with Cortisol or 
dexamethasone and then stimulated by the addition of bacteria were 
similar to those found in the perfused lung system (a reduction in PG 
production by glucocorticoid treatment). This antiphospholipase Ag 
activity was also found in the media, Fran both systems they were 
able to isolate a protein with phospholipase inhibitory activity. The 
molecular weight (MW) of the protein in both cases was 15 kilodaltons 
(Kd); they named this molecule macrocortin (83). 
Blackwell et al. (84) found that while the peritoneal lavage 
fluid of control rats contained a small amount of PLAg inhibitory 
activity it was greatly increased when the rats were treated with 
dexamethasone. In addition, adrenocorticotropic hormone or stress 
(maintaining rats in cold room for 30 minutes) also increased 
macrocortin recovery, and injections of protein or RNA synthesis 
inhibitors along with the dexamethasone diminished the amount 
recovered (84,85). However, when the proteins were purified from the 
peritoneal lavage fluid several peaks with anti-phospholipase activity 
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were recovered with the majority of the activity in the 40 Kd not the 
15 Kd MW range (although an active 15 Kd peak was also found). Unlike 
the original work they had used protease inhibitors in these 
experiments. They concluded that the 15 Kd protein was probably a 
degradation product of the 40 Kd protein (85). 
Blackwell et al. (84) were able to demonstrate that macrocortin 
had anti-inflammatory activity by injecting macrocortin along with 
carrageenan into the pleural cavity of rats. The macrocortin caused a 
reduction in the inflanmatory response in this modified rat pleurisy 
edema test. They also raised a monoclonal antibody to macrocortin and 
were able to neutralize the inhibitory effect of dexamethasone both in 
vitro and in vivo with the antibody (85). 
At the same time Hirata et al. (82) had discovered that 
incubation of rabbit peritoneal neutrophils with various 
glucocorticoids resulted not only in a diminished chemotactic response 
by these cells but also a decrease in the amount of arachidonic acid 
released. Inhibitors of RNA and protein synthesis were able to 
suppress the glucocorticoid action as did treatment of the cells with 
protease. Gel filtration chromatography of cell membrane proteins 
labeled with H-lysine revealed a 40 Kd protein which had marked PLAg 
inhibitory activity and whose production was dramatically increased by 
glucocorticoid treatment. This purified protein was able to block the 
FMLP induced chemotactic response of neutrophils. The PLAg inhibitory 
activity was also found in the culture media. Hirata's group 
christened this molecule lipomodulin. Since that time Flower's group 
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and Hirata's group have come to recognize macrocortin/1ipcraodulin as 
the same molecule and have agreed on the name lipocortin (86). 
Like Blackwell et al., Hirata et al, (87) have also produced a 
monoclonal antibody to lipocortin. Immunoprecipitation of the media 
in which neutrophils are incubated with glucocorticoid has revealed 
proteins of a variety of molecular weights which react with the 
antibodies. However, a 16 Kd protein which reacts with the antibody 
and is probably the same as Blackwell's 15 Kd protein, had no PLAg 
inhibitory activity, Hirata et al, suggested that this molecule was 
perhaps a phosphorylated, inactive form of lipocortin. Treatment with 
alkaline phosphatase resulted in the 16 Kd molecule having PLAg 
inhibitory activity (88), Further studies in this area by Hirata 
confirmed that the regulation of lipocortin was dependent on 
phosphorylation-dephosphorylation, When phosphorylated by protein 
kinase A or C or a tyrosine phosphorylating kinase, lipocortin was no 
longer able to inhibit PLAg, Dephosphorylation restored this activity 
(89), PLAg is believed to be activated by the binding of calcium 
ions, Hirata has suggested that lipocortin acts by interfering with 
the binding of calcium by binding to the same site on the PLAg enzyme 
(90), 
Analysis of the properties of lipomodulin indicate that it is 
approximately 10% carbohydrate with an isoelectric point of 9,4, The 
MW of this molecule has been found to vary somewhat depending on the 
species. However, monoclonal antibodies to rat lipomodulin can cross 
react with similar molecules in mice, rabbits and humans suggesting 
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that structural similarities exist (6). 
By regulating arachidonic acid release lipocortin has been shown 
to limit the inflammatory response, presumably by lowering the 
synthesis of arachidonic acid metabolites which modulate this 
response. In addition lipocortin has also been found to play a role 
in the regulation of suppressor T cell (T^) activity. It was found 
that approximately half the patients with systemic lupus erythematosus 
(SLE) and rheumatoid arthritis, when screened, had antibodies against 
lipocortin (87). Autoantibodies in these conditions are typical and a 
dysfunction of cells has been reported in these patients; therefore 
Hirata decided to study the effects of lipocortin on T-cell activity 
in order to understand what role these antilipocortin antibodies might 
play in the pathogenesis of these diseases. 
It was found that incubation of thymocytes with lipocortin could 
generate in culture (91). In addition, the use of antilipocortin 
antibodies resulted in a loss of cells. The antibody had no effect 
on existing T lymphocytes indicating that the antibody may act at the 
stage of suppressor T cell generation. The results indicate that 
lipocortin may be one of the suppressor inducing factors. Furthermore 
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anti-I-J gene antibodies precipitated l-lipocortin, suggesting that 
lipocortin might be a product of the I-J gene. Analysis of T-cell 
subsets revealed that lipocortin is secreted from Lyt 1~2^, I-j"*" cells 
(90,91). 
One reason the actions of glucocorticoids on neutrophil function 
has been so extensively investigated is to facilitate the development 
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of methods for preventing or overcoming these glucocorticoid effects. 
While at times the anti-inflammatory actions are desired; there are 
other instances e.g. during periods of stress, when it would be 
advantagous for the immune system to be unaltered by the steroids. 
While a number of immunomodulators have been tested in vivo and/or in 
vitro for their ability to inhibit the actions of glucocorticoids on 
bovine neutrophils (13,92,93,94), none so far have been completely 
successful. Part of this research involved the evaluation of the 
immunomodulator, tuftsin, both in vitro and in vivo on normal and 
dexamethasone-treated bovine neutrophils. The following is a summary 
of the of effects of tuftsin on neutrophils and macrophages from 
several different species. 
Immunomodulation by Tuftsin 
The tetrapeptide tuftsin was discovered by Victor Najjar in the 
late 1960s (95). While studying the molecular consequences of 
antibody-antigen interactions he found that sane cytophilic 
gannmaglobul ins had certain physiological functions Wien added to 
certain cell types. Granulocytes, monocytes, macrophages, 
erythrocytes and platelets were found to bind the gammaglobulin in 
vivo and in vitro. This gammaglobulin fraction was called leukokinin. 
It was found only in phosphocellulose fraction IV of fractionated 
gammaglobulin and its concentration is considerably reduced following 
splenectomy, Leukokinin was found to enhance the phagocytic capacity 
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of leukocytes and further studies revealed that the entire molecule 
was not required for activity but only a small fragment. This 
fragment was isolated and sequenced (threonine-lysine-proline-
arginine). Thus leukokinin was considered a carrier molecule for the 
tetrapeptide, tuftsin (96,97). Tuftsin was so named in honor of Tufts 
University, vAiere it was discovered. 
Najjar et al. (98,99) found that the enzyme leukokininase which 
is found on the surface of leukocyte manbranes acts to cleave the 
amino-terminal residues vrtiile an enzyme present in the spleen, 
endocarboxypeptidase, cleaves the carboxy-terminal residues. In this 
way tuftsin is freed from the carrier molecule so that it can bind to 
its own receptors. 
Tuftsin may be inactivated by cleavage of the threonine amino 
acid creating a tripeptide which is a strong inhibitor of tuftsin 
activity. Every residue is essential for activity. Because of this 
it has been proposed that tuftsin may be self regulating. In 
instances where an excess of tuftsin is formed or added above that 
needed for sufficient occupancy of receptors the tripeptide lysine-
proline- arg in i ne would be formed. This peptide has a high affinity 
for tuftsin receptors and would thus occupy enough receptors so as to 
obliterate or limit the activation of the leukocyte. In many cases, 
excess tuftsin has been shown to be inhibitory (96,99,100,101,102). 
Numerous studies (103,104,105,106) have shown that a variety of 
functions of neutrophils and macrophages can be enhanced by tuftsin. 
Tritsch and Niswander (107) found that tuftsin stimulates the 
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formation of superoxide anion and that this parallels the reduction of 
nitro-blue tetrazoliun dye by PMNs found by Spirer et al. (100). 
Luminol-dependent chaniluminescence was enhanced in normal rat PMNs 
stimulated with opsonized zymosan (108). 
Tuftsin has been shown to enhance the movement of granulocytes 
from capillary tubes and to have enhancing effects on chemotaxis of 
hunan monocytes (109,110). It was also found to be as effective as 
EMLP in stimulating chemotaxis (111). As mentioned previously, it has 
been shown to enhance phagocytic activity by granulocytes and 
macrophages in a number of species including dogs, rabbits, mice and 
guinea pigs (99,101,112,113). In addition. Fisher et al, (114) showed 
that phagocytosis by retinal pigment epithelium in the rat is 
stimulated by intraocular injections of 0.2 ug of tuftsin. 
Florentin et al. (108,115) found that injection of tuftsin 3 days 
before introduction of a T-dependent antigen resulted in a 3 fold 
increase in the number of antibody forming cells in the spleen. 
Augmentation also occurred when a T-independent antigen was used. 
Catane et al. (102) found that short-term parenteral administration of 
tuftsin at appropriate concentrations results in an increase in number 
of all white blood cells in normal proportions, suggesting an effect 
on the bone marrow. 
Cytolytic activity by T-cells, macrophages and NK cells has also 
been found to be enhanced by tuftsin (102,115,116,117). The degree of 
activity varied depending on the model used, Bruley-Rosset et al. 
(118) found that peritoneal cell NK activity was augmented by 
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intraperitoneal injections but no effect was found with i.v. 
administration (114). Stimulation of NK activity in vitro is 
controversial with one group reporting an increase and several 
reporting no effect (96,117,118). 
Tuftsin exerts an antibacterial activity by activating gdiagocytes 
but has also been shown to have a direct bactericidal activity in 
higher concentrations. Blok-Perkowska et al. (119) reported that 
concentrations of 60 ug/ml could destroy several types of bacteria. 
While this concentration is much higher then that normally found in 
the serum (120,121) it may still be useful for direct therapeutic use 
against some bacterial infections. Martinez et al. (122) have studied 
the ability of tuftsin to kill bacteria (Escherichia coli, 
Staphylococcus aureus. Salmonella typhimurimi and Listeria 
monocytogenes) by activation of the leukocytes. They found that the 
nunnber of bacteria internalized by mouse peritoneal macrophages in 
vivo was dramatically increased by intraperitoneal injections of 
tuftsin at 10 and 20 mg/kg. In addition, tuftsin treatment showed an 
augmentation of the clearing from the blood of 4 different bacteria 
(S taphylococcus aureus. Listeria monocytogenes, Escherichia coli and 
Serratia marcescens) (105). 
Cytotoxicity of macrophages towards neoplastic cells fron a 
nunnber of species has been shown to be enhanced by tuftsin treatment. 
This property was not found to be due to a direct effect of tuftsin on 
the target cells. It has been observed in both peritoneal and lung 
macrophages (102,123,124). 
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Little is known about the mechanism of action of tuftsin. It is 
known that tuftsin increases the levels of guanosine-3',5'-
monophosphate (cGMP) by 80 to 90% and at the same time depresses the 
levels of CAMP by 20 to 25% in human PMNs and mouse peritoneal 
macrophages (125). This effect occurs almost immediately and is 
maximal by approximately 20 minutes. It has previously been shown 
that agents which increase cGMP concentrations often enhance certain 
PMN activities while agents vAiich increase cAMP levels decrease 
certain functions (126,127). 
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RELATIONSHIP OF GLUCOCORTICOID SUPPRESSION OF ARACHIDONIC ACID 
METABOLISM TO ALTERATION OF NEUTROPHIL FUNCTION^ 
Abstract 
The role of arachidonic acid metabolism in glucocorticoid-induced 
suppression of neutrophil function was investigated. In vivo 
treatment of cattle with dexamethasone decreased the production of 
lipoxygenase products of arachidonic acid metabolism (leukotriene 
B^(LTB^) and 5-HETE) in neutrophils. We previously reported that in 
vivo dexamethasone treatment resulted in alteration of in vitro 
neutrophil oxidative metabolism, iodination, antibody-dependent cell-
mediated cytotoxicity (ADCC) and random migration. To determine if 
the decrease in production of LTB^ and 5-HETE were responsible for the 
changes in neutrophil function, neutrophils were treated in vitro with 
inhibitors of the lipoxygenase enzyme (BW755c and nordihydroguaiaretic 
acid) and their function was evaluated. A decrease in neutrophil 
oxidative metabolism and iodination was observed but there was no 
effect on neutrophil random migration or ADCC. The results suggest 
that in vivo treatment with glucocorticoids inhibit neutrophil 
oxidative metabolism and iodination by decreasing the formation of 
4).S.A. WdDb and J.A. Roth. 1986. J. Leuk. Biol., accepted for 
publication. 
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lipoxygenase products of arachidonic acid metabolism but alter 
neutrophil random migration and ADCC by a mechanism independent of 
arachidonic acid metabolism. 
Introduction 
It is well-documented that in vivo glucocorticoid treatment 
results in the inhibition of in vitro polymorphonuclear leukocyte 
(PMN) function (1,2,3,4). Wfe have previously reported that 
dexamethasone, a potent synthetic glucocorticoid, v^en administered to 
cattle, significantly decreases PMN iodination, antibody-dependent 
cell-mediated cytotoxicity (ADCC), and oxidative metabolism and 
enhances PMN random migration (5). These alterations in function 
could not be attributed to an increased percentage of immature 
neutrophils in the peripheral blood induced by increased 
glucocorticoid levels (6). 
While attempting to elucidate the anti-inflammatory mechanism of 
glucocorticoids Hirata et al, and Blackwell et al. observed that 
glucocorticoids induce the synthesis of a phospholipase Ag (PLAg) 
inhibitory peptide (lipanodulin, macrocortin) (7,8) in both rabbit 
peritoneal neutrophils and rat peritoneal leukocytes. Upon 
stimulation of neutrophils, PLA^ is activated and acts to release 
arachidonic acid from the cells' phospholipids. This free arachidonic 
acid may serve as a substrate for both the cyclooxygenase and 
lipoxygenase pathways (9). The products of these pathways 
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(prostaglandins, leukotrienes and hydroxyeicosatetraenoic acids) are 
important regulators of certain cellular events (10,11,12). It is, 
therefore, generally concluded that the inhibition of arachidonic acid 
metabolism by a PLAg inhibitory peptide may be a major mechanism of 
action by which glucocorticoids suppress neutrophil functions. 
However, most of the work showing a correlation between 
suppressed neutrophil function and decreased arachidonic acid 
metabolism due to glucocorticoid treatmait addresses only one or two 
neutrophil functions (8,13). As stated previously, we have found that 
at least four different aspects of neutrophil function are altered by 
in vivo glucocorticoid treatment. The purpose of this work was to 
determine if in vivo dexamethasone treatment alters the in vitro 
arachidonic acid metabolism of bovine neutrophils and to determine 
whether such an alteration could be responsible for all of the effects 
of glucocorticoids on neutrophil function. 
Materials and Methods 
Animals 
Twenty-four healthy adult bovine steers were used. Dexamethasone 
(Aziun, Schering Corp, Kenilworth, NJ) (0.04 mg/kg) was administered 
intramuscularly 24 hours before the PMNs were collected. Control 
animals received no treatment. 
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Lipoxygenase and cyclooxyqenase inhibitors 
BW755C ms a gift from Wellcome Research Laboratory (Kent, United 
Kingdon) while nordihyjroguaiaretic acid (NDGA) and indomethacin were 
purchased from Sigma (Sigma Chemical Co., St. Louis, MO). All 
compounds were initially dissolved in dimethyl sulfoxide (DMSO) and 
diluted in 0.015 M phosphate buffered saline solution (pH 7.2} (PBSS) 
to a final concentration of 1.0 mg/ml. Appropriate aliquots were 
added to a suspension of neutrophils at least 15 minutes before an 
assay was started. The highest final concentration of DMSO present 
was 0.05%; this concentration of DMSO in PBSS was found to have no 
effect on neutrophil function and was added to the control cells. 
Isolation of PMJS 
Blood was collected from both control and dexamethasone-treated 
cattle into an acid-citrate dextrose solution by jugular venipuncture. 
Pt-lNs were isolated by a method previously described (14). Briefly, 
the Wiole blood was centrifuged, and the plasma and buffy coat were 
discarded. The remaining RBCs were lysed by a cold hypotonic solution 
for 50 seconds, after which isotonicity was restored by the addition 
of 2.7% NaCl. The cells were pelleted, the lysate discarded, and the 
cells were resuspended in 0.015 M phosphate buffered saline solution 
(PBSS) (E« 7.2), washed twice and enumerated. The final volume was 
adjusted to 5.0 X 10^ cells per ml in PBSS. A smear of the cells was 
stained with modified Wright's stain for differential counting. The 
final cell preparation generally contained greater than 90% Pf-ttJs. 
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Labeling of PMJS with ^ =^-arachidonic acid 
Twenty-five ul (8 X lO^cpms) of [1-^^C]-arachidonic acid (59.6 
mCi/imol) (Amersham Corp., Arlington Heights, IL) was added to a 
clean, dry test tube and evaporated to dryness under Ng. The cell 
suspension (10 ml) was immediately added, and the cells were then 
incubated with the ^^C-arachidonic acid in a shaker water bath at 37°C 
for 2 hours. After labeling, the cells were washed twice with PBSS to 
remove excess free arachidonic acid and resuspended at 5.0 X 10^/ml in 
Gey's Balanced Salt Solution (GBSS). 
PMJ stimulation and lipid extraction 
One ml aliquots of the labeled cells were added to individual 
test tubes, and one ml of opsonized zymosan as a stimulus (10 mg/ml in 
GBSS, prepared as previously described) (14) was added to the 
experimental tubes while the nonstimulated controls received 1 ml 
GBSS. The reaction was stopped at 0, 5, 15, 30 and 60 minutes after 
the addition of zymosan by the addition of 4.0 ml chloroform/methanol 
(l:lv/v) containing 0.001% butylated hydroxytoluene and 0,1 ml 2% 
formic acid. The suspension was vortexed and held at 4°C overnight. 
The organic layer was ramoved after centrifugation, evaporated to 
dryness under Ng and resuspended in 1 ml ethyl acetate. The ethyl 
acetate solution was put on a silicic acid column (5mm in diameter, 
approximately 0.5 grams of silicic acid). Neutral lipids were eluted 
with 15 ml ethyl acetate followed by the elution of the phospholipids 
with 15 ml of methanol. 
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Thin Layer Chromatography 
Both neutral lipids and phospholipids were evaporated to dryness 
under Ng, resuspended in 200 ul of ethyl acetate for the neutral 
lipids and methanol for the polar lipids and then spotted on separate 
thin layer chromatography plates (Silica Gel G, Analtech, Newark, DE). 
Neutral lipids were developed in a solvent system containing 
hexane/ethyl ether/acetic acid (60:40:lv/v/v/), while the 
phospholipids were separated by a system consisting of 
chloroform/ethyl acetate/l-propanol/methanol/0.25% KCl 
(25:25:25:19:9v/v/v/v/v) (15). 
Lipid fractions were located by autoradiography and scraped into 
liquid scintillation vials containing 20 mis of toluene-based 
scintillation fluid (Research Products Inc., Elk Grove, IL). After 
counting in a liquid scintillation counter, quenching by the silica 
acid gel was corrected for by use of a quench curve. The percent of 
the total dpms in each lipid class for each time period was 
calculated. The difference in % dpm of each lipid from the % dpn of 
that lipid at time zero (time at which zymosan was added) was then 
determined, and the statistical significance was evaluated using an 
analysis of variance procedure. 
Identification of the lipids 
Ccmigration of standards was used to identify all lipids except 
leukotriene B^. The standards for triacylglyceride mixtures, 
diacylglyceride mixtures, arachidonic acid, phosphatidylcholine. 
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phosphatidylethanolamine, phosphatidylinositol, phosphatidylserine and 
sphingcmyelin (Sigma, St. Louis, MO) were located by vapors. A 
5-hyaroxy-6,8,11,14-eicosatetraenoic acid (5-HETE) standard was 
purchased from New England Nuclear (Boston, MA) and was located by 
autoradiography. Leukotriene (LTB^) was identified by comparing 
the observed Rf value with a published Rf value for LTB^ using the 
same solvent system (16). In addition the area containing the LTB^ 
was scraped fron the TLC plate, and the product eluted in methanol. 
The UV spectra was checked and matched that reported for leukotriene 
B^ by Jakschik et al. (17). 
Evaluation of PMJ function 
The procedures for evaluating bovine PMN random migration, S. 
aureus ingestion, cytochrome C reduction, iodination, and antibody-
dependent cell-mediated cytotoxicity (ADCC) have been described in 
detail (14,18,19). Briefly, PMN randan migration was evaluated by 
measuring the area of random migration under agarose after an 18-hour 
125 incubation period (14). Ingestion of opsonized I-iododeoxyuridine-
labeled aureus was evaluated using a PMN to ^  aureus ratio of 1 to 
60, an incubation period of 10 minutes, and lysostaphin to remove the 
extracellular S. aureus (14). The results were expressed as the 
percent of the ^  aureus present that was ingested. Cytochrome C 
reduction was determined using a microtiter procedure with opsonized 
zymosan as the stimulant and a 30-minute incubation period (19). The 
results were expressed as the optical density (at 550 nm) per 1.25 X 
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10® PMNs, The O.D. for unstimulated PMNs was subtracted from the O.D. 
for stimulated PMNs. The activity of the myeloperoxidase-hySrogen 
peroxide-halide antibacterial system of the PMN was evaluated by the 
iodination reaction using a 20-minute incubation period, opsonized 
zymosan as the stimulating particle, and trichloroacetic acid to 
precipitate the bound iodine (14). The ability of PMNs to mediate 
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ADOC was evaluated using Cr-labeled chicken erythrocytes as target 
cells with an effeetor-to-target ratio of 10 to 1, bovine antibody, 
and a 2-hour incubation period (20). 
Results 
The distribution of the radioactivity from the arachidonic 
acid found in the various lipids after the 2 hour labeling period is 
shown in Table 1. There was no significant difference in the amount 
or distribution of the radioactivity between the control and 
dexamethasone-treated PMNs. An average of approximately 50,000 dpus 
7 
was recovered from 5.0 X 10 PMNs, Because the total amount of 
radioactivity recovered fran each time period varied, it was necessary 
to express the amount of radioactivity recovered in each lipid 
fraction as the percent dpms of the total dpns recovered for that time 
period. In order to study the kinetics of the reaction the % dpms in 
each lipid fraction at either 5, 15, 30 or 60 minutes were subtracted 
from the % dpms in the same lipid fraction at time zero so that the 
data are expressed as the change in % dpms fron time zero for each 
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Table 1. Distribution of ^ ^C-arachidonic acid in lipid fractions 
of PMNS from control and dexamethasone treated cattle 
Percent total radioactivity incorporated 
Lipid fraction Control Dexamethasone 
LTB4 0.7®+ 0.2 0.5 + 0.2 
5-HETE 1.0 + 0.1 0.9 + 0.2 
D iacylglycer ides 4.5 + 2.5 5.7 + 1.8 
Arachidonic acid 5.9 + 1.5 6.2 + 0.9 
Tr iacylglycer ides 48.8 + 4.0 53.1 + 2.6 
Phospholipids 39.1 + 4.1 33.3 + 3.5 
Values represent the mean values 2 SEM (n = 6). An average of 
approximately 50,000 dpms was recovered in each group. There were no 
significant differences between the groups. 
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lipid fraction. Time zero was the moment at vAich the opsonized 
zymosan was added. Table 2 shows the actual values for cells from 
control and dexamethasone treated animals at 0 and 15 minutes and how 
the % change in dpms was derived. 
The changes in radioactivity levels in the different lipid 
fractions of unstimulated neutrophils (no opsonized zymosan added) 
after the cells were washed and resuspended in GBSS was determined. 
In neutrophils from both control and dexamethasone-treated cattle 
there was a transfer of radioactivity primarily from the 
triacylglycerides to the other lipids over the 60 minute time period. 
While there was a tendency for this transfer to be larger in the 
control group, the difference between the two groups was not 
statistically significant. The amount of radioactivity found in the 
areas on the TIC plates where LTB^ and 5-HETE are expected to migrate 
was barely detectable in nonstimulated cells (Table 1). 
The addition of opsonized ^osan to the control PMNs (Fig. 1) 
resulted in a release of arachidonic acid from the phospholipids and 
production of 2 new metabolites. These metabolites were identified as 
leukotriene and 5-HETE using the criteria described in the 
materials and methods section. The radioactivity initially lost from 
the phospholipids is completely recovered by 60 minutes apparently due 
to transfer of radioactivity from the triacylglycerides or 
reincorporation of new metabolites into the phospholipids. The 
standard error bars are not shown in Fig. 1 but are shown in Figs. 2a-
2f vAich compare the responses of neutrophils from control and 
Table 2. Calculation of change in percent dpm from time zero for control 
cells incubated for 15 minutes with opsonized zymosan^ 
0 min 15 min change in %dpm 
Lipid fraction dpm %dpm dpm %dpm (%dpm 15 min-%dpm 0 min) 
LTB^ 286 0.8 1,194 3.5 +2.7 
5-HETE 535 1.5 1,472 4.3 +2.8 
D iacylglycer ides 2,770 7.9 2,995 8.8 +0.9 
Arachidonic acid 1,006 2.9 2,259 6.7 +3.8 
Tr iacylglycer ides 12,267 35.1 13,739 40.5 +5.4 
Phosfdiolipids 18,066 51.7 12,218 36.1 -15.6 
Total dpm 34,930 33,877 
^he % change in dpm at the different time periods was calculated for 
each animal, the values were averaged and the statistical significance 
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Fig. 1. Kinetics of the arachidonic acid metabolism of bovine 
PMNs in response to opsonized zymosan. Points represent 
the mean change in percent radioactivity from time zero of a 
particular lipid fraction, n = 6 
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dexanethasone-treated cattle. 
The kinetics of the response to opsonized zymosan of PMNs from 
the dexamethasone-treated animals was similar to that of the controls; 
however, the amount of arachidonic acid released fran phospholipids 
and correspondingly the amount of new metabolites formed were 
significantly less (Pigs. 2a-f). Fig. 2a compares the loss of ^ ^C-
arachidonic acid from the phospholipids of the control and 
dexamethasone-treated PMNs. In both groups the peak release was at 15 
minutes. The difference in amount released between the control and 
dexamethasone group was significant at both 15 and 30 minutes. The 2 
new metabolites are compared in Figs. 2e and 2f. The amount of LTB^ 
in the control group had a rapid increase for 15 minutes after 
stimulation then increased at a much slower rate (Fig. 2e). The 
amount of free LTB^ in the PMNs from the dexamethasone-treated group 
was equivalent to the controls for the first 5 minutes, but did not 
increase from that point and was significantly lower than the controls 
at 15, 30 and 60 minutes. Fig. 2f shows the difference in the amount 
of free 5-HETE production. The 5-HETE had a tendency to peak at 15 
minutes in the control group and at 5 minutes in the dexamethasone-
treated group. After peaking there was a decline in the amount of 5-
HETE in the both groups. Although there is no statistically 
significant (P > 0.05) difference between the two until 60 minutes, 
there was only 1 experiment out of 6 in which the dexamethasone-
treated cells yielded a higher amount of 5-HETE than the controls. If 
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in the different lipid fractions of the control (o o) 
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significant at 15, 30 and 60 minutes. 
Figures 2c and 2d show the change in diacylglycerides and free 
arachidonic acid for the PMNs from control and dexamethasone-treated 
animals. The PMNs from dexamethasone-treated animals had less change 
of both substances at all time periods; the difference was only 
significant at the 30 minute time period (P < 0.05). Fig. 2b compares 
the changes in the triacylglycerides. There was no significant 
difference between the two at any time. However, there was a tendency 
for the dexamethasone-treated cells to lose radiolabel from the 
triacylglycerides at 5 minutes while the control cells gained 
radiolabel at that time. 
In order to better compare and summarize the difference between 
the control and dexamethasone-treated cells, the relative areas under 
the curves in Figs. 2a-f were determined (Fig. 3). The data are 
displayed as the area under each curve relative to the area under the 
control diacylglyceride curve as a standard. 
Having established that dexamethasone treatment suppresses 
arachidonic acid metabolism of bovine neutrophils, 2 lipoxygenase 
inhibitors were then added in vitro to the neutrophils and the various 
functions tested. This was done in order to determine which if any 
of the neutrophil functions are dependent on arachidonic acid 
metabolism. Tables 3, 4 and 5 show the effects of NDGA, BW755c and 
indomethacin at different concentrations on neutrophil random 
migration, ingestion, cytochrome C reduction, iodination and ADCC. 






Areas under the curves in figures 2a-f relative to the 
area under the control diacylglyceride curve 
Table 3. The effects of nordihySroguaiaretic acid (NDGA) on neutrophil^ 
function 
Conceitration Random Cytochrane C 
(ug/ml) migration Ingestion reduction lodination ADGC 
0 100 100 100 100 100 
1 101.0 + 3.6 113.7 +5.1 84.0 + 4.0^ 90.3 + 4.6 102.2 +7.4 
10 103.6 +4.9 109.4 +5.4 71.1 + 5.9^ 66.9 + 7.6^ 91.1 + 4.4 
50 105.8 +5.6 107.4 +4.4 35.6 + 4.5^ 53.8 + 6.1° 92.8 + 3.3 
100 89.4 + 7.1^ 69.4 + 7.6^ 13.7 + 5.0° 7.9 + 3.2° 22.9 + 5.7° 
n = 5 n = 6 n = 6 n = 5 n = 8 
^WNs were preincubated for 15 minutes in the indicated concentration of 
inhibitor before the start of the assays. Values are expressed as mean 
(j^SEM) percent of the value for control (untreated) neutrophils. 
^P<0.05. 
^P<0.01. 
Table 4. Effects of BW755c on neutrophil^ functions 
Concentration Random Cytochrome C 
(ug/ml) migration Ingestion reduction lodination ADCC 
0 100 100 100 100 100 
1 97.5 + 1.1 100.1 + 7.1 94.1 + 6.2 86.5 2 6.6 102.3 +6.6 
10 100.0 +2.1 99.3 + 5.3 83.1 + 5.6 77.3 + 7.3^ 99.3 + 6.5 
50 98.8 + 1.5 111.7 +9.7 62.2 + 9.3^ 69.9 + 7.2^ 96.2 + 6.4 
100 97.0 + 2.1 96.7 + 2.1 58.4 + 10.9^ 55.5 + 4.9^ 92.2 + 6.4 





^PMNs were preincùbated for 15 minutes in the indicated concentration of 
inhibitor before the start of the assays. Values are expressed as a mean (_+SEM) 
percent of the value for control (untreated) neutrophils. 
^P<0.05. 
^P<0.01. 
Table 5. Effects of indonethacin on neutrophil^ functions 
Concentration Random C^ochrone C 
(ug/ml) migration Ingestion reduction lodination ADCC 
0 100 100 100 100 100 
1 97.6 + 1.3 99 .2 + 4.3 113.1 + 6.9 97.0 + 2.8 93.0 + 10.7 
10 94.3 + 6.6 107 .6 ^  3.6 106.0 +4.6 102.6 +6.3 107.7 +5.5 
50 99.5 + 1.4 117 .4 + 10.2 102.5 +9.2 101.6 + 5.3 110.6 + 8.6 
100 95.4 + 3.9 109 .8 + 11.2 119.6 + 8.0 89.2 + 8.0 98.1 + 10.1 
n = 7 n = 6 n = 6 n = 5 n = 5 
^PMNs were preincùbated for 15 minutes in the indicated concentration of 
inhibitor before the start of the assays. Values are expressed as a mean (j^SEM) 
percent of the value for control (untreated neutrophils). No significant 
differences were observed due to indomethacin. 
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iodination and cytochrome C reduction at concentrations which did not 
affect the other functions. At 100 ug/ml of NDGA all the functions 
where affected; this concentration was considered toxic to the cells 
(Table 3). Indanethacin did not affect any of the functions at any of 
the concentrations used. The values are given as a percent of the 
value for the untreated (control) PMNS. The mean (+ SEM) (n = 19) of 
the actual control values were: random migration, 32.8 +8.8 mm^; S. 
aureus ingestion, 29.4 + 3.4%; cytochrome C reduction, 0.213 + 0.014 
O.D. at 550nn; iodination, 36.6 + 3.8 nmoles NaI/10^ PMN/hour; ADCC, 
54.8 + 7.4 % ^^Cr release. 
In order to determine the specific effects of NDGA, BW755c and 
indomethacin on arachidonic acid metabolism of neutrophils, the PMNs 
were labeled with ^^C-arachidonic acid, and the arachidonic acid 
metabolism was evaluated as described above. All inhibitors were used 
at the same concentration (50 ug/ml). The NDGA inhibited the 
production of the lipoxygenase products and may have inhibited the 
release of arachidonic acid since significantly less free arachidonic 
acid was found at 15 minutes after stimulation (Table 6). An amount 
of free arachidonic acid similar to the controls was found when BW755c 
was used; however, there was very little production of the 
lipoxygenase products. Indomethacin did not inhibit the production of 
either LTB^ or 5-HETE. 
Viability of the neutro#iils at 50 ug/ml of each inhibitor was 
checked using trypan blue exclusion. After two hours incubation there 
was no significant affect on cell viability. In addition, the 
Table 6. Effects of lipoxygenase and cyclooxygenase inhibitors on the 
arachidonic acid metabolian of bovine neutrophils 
% change in DPMs from time zero 
Control BW755c NDGA Inâonethacin Lipid fraction 
LTB4 3.3®+ 0.2 0.3 + 0.2^ 0.2 + 0.1^ 3.1 + 0.4 
5-HETE 2.2 + 0.3 0.1 + 0.3^ 0.2 + 0.1^ 1.8 + 0.3 
Diacylglycerides 1.4 + 0.3 0.4 + 0.7 0.1 + 0.3^ 0.5 + 0.7 
Arachidonic acid 3.1 + 0.5 5.3 + 2.2 0.6 + 0.6^ 2.4 + 1.0 
Triacylglycer ides -5.9 + 1.2 -0.2 + 2.4 1.1 + 1.8^ -0.6 + 2.7 
Phospholipids -3.9 + 1.6 —6.0 ^  1.4 -2.1 + 1.4 -7.3 + 1.2^ 
Values represent the mean + SEM of the change in the % DPMs of each lipid 
fraction 15 minutes after stimulation with opsonized zymosan compared to zero 
time (before the addition of opsonized zymosan). Concentration of each inhibitor 
was 50 ug/ml, n = 6. 
^P<0.01, compared to control values. 
^P<0.05, compared to control values. 
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neutrophils treated with each inhibitor at 50 ug/ml gave random 
migration, ^  aureus ingestion and ADCC values similar to the controls 
indicating that the cells were viable and functioning. 
Discussion 
Stimulation of bovine PMNs with opsonized zymosan resulted in the 
release of free arachidonic acid from phospholipids and the production 
of 2 arachidonic acid metabolites. The radioactivity was initially 
lost from the phospholipids, but was recovered by 60 minutes 
apparently by transfer of arachidonic acid from the triacylglycerides 
into the phospholipids or transfer of the new metabolites into the 
phospholipids. 
The lipoxygenase products 5-HETE and LTB^ were the only 
detectable arachidonic acid metabolites formed. These 2 lipoxygenase 
products have been shown to have a variety of effects on neutrophil 
functions. LTB^ aggregates neutrophils and is capable of inducing 
degranulation (20,21). It has been shown that LTB^ rapidly increases 
the uptake of Ca^^ by neutrophils, and its potentiation of Ca"*"^ uptake 
closely parallels not only its secretory activities but also its 
chemotactic and aggregatory properties. Stimulation of neutrophils by 
receptor-1igand interactions produces changes in the intracellular 
levels of exchangeable Ca^^ which are essential for many processes. 
It has been suggested that the LTB^ is formed in response to stimuli 
and is capable of increasing Ca^^ mobilization, thereby amplifying the 
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neutrof^ils response to the original stimulus (22,23). 
The other major product found, 5-HETE, has been shown to alter 
membrane properties and to be chemotactic for neutrophils (24,25,26). 
Bonser et al. and Stenson and Parker found that 5-HETE is 
reincorporated into the phospholipids and triacylglycerides of the 
cells and suggest that this re-esterification of 5-HETE acts to alter 
the fluidity of the membrane (4,26). It was not determined in this 
study if the 5-HETE produced was reincorporated into the 
phospholipids, however if this were the case, it could explain why the 
concentration of 5-HETE peaks at 15 minutes and then steadily declines 
with time (Fig. 2f) and why the amount of radioactivity in the 
phospholipids increases after the initial drop (Fig. 2a). 
It is interesting to note that at times some of the arachidonic 
acid released appears to cane fran the triacylglycerides as well as 
the gAospholipids (Fig. 2, Table 6). It is possible that the 
triacylglycerides as well as the phospholipids serve as a pool for 
arachidonic acid. Haye et al. report that arachidonic acid is 
released and utilized for prostaglandin production by thyroid tissue 
in response to thyroid stimulating hormone (27). They suggest that 
there are two pools of arachidonic acid available: the phospholipids 
and the triacylglycer ides. It is obvious that arachidonic acid is 
taken up by and released from tr iacylglycer ides, but the role for 
triacylglycerides as a source of arachidonic acid in stimulated 
neutrophils is not clear. 
Another possible source of arachidonic acid is the 
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diacylglycerides. It has been shown in some instances that 
phospholipase C can convert phosphatidylinositol to a diacylglyceride 
which is further degraded by a diacylglyceride lipase to a 
monoacylgyceride and arachidonic acid (28). Figure 2c shows a 
significant difference in the amount of diacylglycerides produced by 
cells fron control verses dexamethasone treated animals upon 
stimulation with opsonized zymosan. In this study it ag^ars that the 
phospholipids are the primary arachidonic acid source, however the 
contribution of triacylglycerides or the diacylglycerides was not 
determined. 
Neutrophils from animals treated with dexamethasone released 
significantly less arachidonic acid frcm the phospholipids than 
neutrophils fron control animals and subsequently produced less of the 
new metabolites. This could be explained by the induction of a 
lipomodulin-like molecule by the dexamethasone treatment in either the 
neutrophils or sane other cell. However, we did not find in vitro 
suppression of neutrofAiil functions after a 3 hour in vitro treatment 
with glucocorticoids. Hirata et al. (8) state that an incubation of 
16 hours in vitro is necessary for maximal production of lipcmodulin 
by neutrophils. We have been unable to incubate the cells that long 
and have them remain viable and unclumped. An alternate explanation 
is that another cell type is responsible for the liponodulin-like 
activity. Whether the steroid acts indirectly on the neutrophil via 
another cell type or simply requires lengthy in vitro incubation 
remains unclear at this point. 
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As mentioned previously, several different aspects of neutrophil 
function are altered by in vivo treatment with dexamethasone (4). In 
order to determine if any of these functions are dependent on 
arachidonic acid metabolism vie used 2 lipoxygenase inhibitors and a 
cycl©oxygenase inhibitor on neutrophils and then evaluated 5 aspects 
of their function: random migration, ^  aureus ingestion, cytochrome 
C reduction, iodination, and ADCC. The results indicate that only 
iodination (a measure of the myeloperoxidase-hyârogen peroxide-halide 
antibacterial activity of the neutrophil and an indirect measure of 
degranulation) and cytochrome C reduction (a measure of superoxide 
anion production) were suppressed by the lipoxygenase inhibitors NDGA 
and BW755C (Tables 3 and 4). Indomethacin (a cyclooxygenase 
inhibitor) had no effect on any of the functions (Table 5). This 
would be expected since no detectable cyclooxygenase products were 
produced by the stimulated neutrophils. 
The induction of a phospholipase inhibitory protein 
(lipcraodulin) by glucocorticoid resulting in decreased release of 
arachidonic acid has been proposed as a mechanism whereby 
glucocorticoids inhibit neutrophil function. Our data are compatible 
with this hypothesis in that neutrophils from cattle treated with 
dexamethasone had less free arachidonic acid released and a decreased 
production of arachidonic acid metabolites upon stimulation with an 
opsonized particle. However, the lipomodulin-like molecule may have 
been produced by a cell other than the neutrophil. Our data also 
indicate that an inhibition of phospholipase A^ cannot account for all 
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of the in vivo effects of glucocorticoids on neutrophil function. 
Potent inhibitors of the lipoxygenase enzyme (NDGA. and BW755c) were 
found to inhibit the production of 5-HETE and LTB^ by neutrophils 
(Table 6) and to inhibit neutrophil oxidative metabolism and 
iodination (Tables 3 and 4). These inhibitors did not affect 
neutrophil random migration or neutrophi1-mediated ADCC, two functions 
which are altered by in vivo treatment of cattle with dexamethasone. 
Frank and Roth (accepted for publication, J. Leukocyte Biol.) provide 
evidence that bovine monocytes, treated in vitro with hydrocortisone 
release a substance(s) which enhances neutrophil random migration and 
inhibits neutrophi1-mediated flDCC. Together, the inhibition of 
neutrophil arachidonic acid metabolism and the hydrocortisone-induced 
monocyte factor(s) can mimic in vitro the observed in vivo effects of 
glucocorticoids on bovine neutrophil function. 
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EVALUATION OF THE IN VITRO AND IN VIVO EFFECTS OF TUFTSIN ON NORMAL 
AND SUPPRESSED BOVINE NEUTROPHILS 
Abstract 
Previous work has shown that dexamethasone alters a nunber of 
neutrophil functions thus increasing the host's susceptibility to 
infectious diseases. The purpose of this study was to evaluate the 
possibility of using the irnnunomodulator, tuftsin, to overcome the 
suppressive effects of glucocorticoids on bovine neutrophils. Tuftsin 
was evaluated for its in vitro influence on neutrophils from 
nontreated and dexamethasone-treated animals. Tuftsin was also 
administered in vivo at a variety of dosages to normal cattle and to 
cattle treated concurrently with dexamethasone and the neutrophil 
functions evaluated. The results were found to vary depending on the 
conditions under vAiich tuftsin was used. In vitro tuftsin treatment 
of normal bovine neutrophils resulted in increased iodination and 
ingestion responses, v^ile in vivo treatment of nondexamethasone-
treated animals revealed a significant effect on cytochrome C 
reduction. Tuftsin had no significant effect in vitro on neutrophils 
from dexamethasone-treated animals. However, when tuftsin was 
administered in conjunction with dexamethasone, a consistent 
significant alteration of the dexamethasone effect on neutrophil 
random migration was observed. In addition, the iodination response 
was significantly enhanced over that of neutrophils fran cattle v^ich 
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received dexamethasone alone and there was a tendency for the ADCC 
response to be enhanced. We have concluded that in vivo tuftsin may 
be working indirectly to exert its effect on neutrophil random 
migration. The results indicate that tuftsin treatment will partially 
overcome sane of the suppressive effects of glucocorticoids on 
neutrophil function. 
Introduction 
The tetrapeptide tuftsin has been reported to have a variety of 
immunomodulating effects on neutrophils and macrophages from a number 
of different species (1,2,3). First recognized because of its ability 
to enhance E^agocytosis (4); it has since been reported to stimulate 
superoxide anion production, to alter migration of phagocytes, to 
increase bactericidal and tumoricidal activity of leukocytes and to 
enhance the antibody response to antigens (5,6,7,8,9). 
Our laboratory has previously investigated the suppression of 
bovine neutrophil function due to in vivo glucocorticoids and the 
mechanisms involved in this suppression (10,11,12). Dexamethasone 
administered to cattle leads to increased neutrophil random migration 
and suppressed neutrophil oxidative metabolism, iodination, and 
antibody-dependent cell-mediated cytotoxicity (ADCC) (10). It was 
determined that suppressed neutrophil oxidative metabolism and 
iodination are due to the suppression of neutrophil arachidonic acid 
metabolism and that increased neutrophil random migration and 
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suppressed WXÎC are mediated by factors produced by the monocytes in 
response to glucocorticoids. In addition, a variety of compounds have 
been tested in vitro and/or in vivo, for their ability to prevent or 
reverse the effects of dexamethasone on neutrophils (13,14,15,16,17). 
.V 
The purpose of this study was to evaluate the ab'ility of tuftsin to 
reverse the suppressive effects of a potent glucocorticoid, 
dexamethasone, on bovine neutrophils. Tuftsin was added in vitro to 
neutrophils from nontreated and dexamethasone-treated cattle and the 
neutrophil functions evaluated. Tuftsin was also administered in vivo 
to cattle either alone or with dexamethasone to determine its in vivo 
effects on neutrophil function. 
Materials and Methods 
Animals 
Twenty-four healthy adult steers ware used in this study. 
Dexamethasone (Aziun, Schering Corp, Kenilworth, NJ) (0.04mg/kg) vas 
administered intramuscularly (i.m.) 24 hours before the 
polymorphonuclear leukocytes (PMNs) were collected for evaluation of 
in vitro tuftsin effects. Control animals received no treatment. 
For the evaluation of in vivo tuftsin effects, tuftsin was 
injected intravenously (i.v.) 24 hours before the first bleeding. In 
cases where tuftsin and dexamethasone were both used, the tuftsin was 
administered 24 hours before the first dexamethasone injection and 
cattle were then bled 24 hours following the first dexamethasone 
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injection. The treatment was continued daily with either tuftsin, 
dexamethasone, or both for the duration of the experiment. In all 
experiments each group (5 animals) was bled daily for a total of 3 
consecutive days. Animals were bled on two separate days before each 
experiment and the PMN functions evaluated. Animals were then divided 
into groups so that there were no pre-existing significant differences 
in the neutrogAiil functions. 
Isolation of PffJs 
Blood was collected from both control and dexamethasone-treated 
cattle into an acid-citrate dextrose solution by jugular venipuncture. 
PMNs were isolated by a method previously described (18). Whole blood 
was centrifuged, and the plaana and buffy coat were discarded. The 
red blood cells (RBCs) were lysed by a cold hypotonic solution for 50 
seconds, after which isotonicity was restored by the addition of 2.7% 
NaCl. The cells were pelleted by centrifugation, the lysate discarded 
and the cells resuspended in 0.015M phosphate buffered saline solution 
(PBSS) (pH 7.2). The lysing procedure was repeated to lyse the 
remaining RBCs and the PMNs were resuspended in PBSS and adjusted to a 
final concentration of 5.0 X loVml. 
Reagents 
Tuftsin (Sigma Chemical Co., St. Louis, MO) was dissolved in PBSS 
and stored at -70°C at a concentration of 2.0 mg/ml. Immediately 
before use an aliquot was thawed, diluted to the appropriate 
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concentration in PBSS and added to the cells or injected into the 
animals. 
PftJ functional evaluation 
The procedure for evaluating bovine PMN randan migration. 
Staphylococcus aureus ingestion, cytochrone C reduction, iodination 
and ADCC have been described in detail (17,18,19). Briefly, PMN 
randan migration was evaluated by measuring the area of randan 
migration under agarose after an 18-hour incubation period (18), 
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Ingestion of opsonized I-iododeoxyuridine-labeled S. aureus was 
evaluated using a PMN to ^  aureus ratio of 1 to 60, an incubation 
period of 10 minutes and lysostaphin to ranove the extracellular S. 
aureus (18). The results were expressed as the percent of ^  aureus 
present which was ingested. Cytochrone C reduction was determined 
using a microti ter procedure with opsonized zymosan as the stimulant 
and a 30 minute incubation period (17). The results were expressed as 
the optical density (at 550nm) per 1.25 X 10^ PMNs. The O.D. for 
unstimulated PMNs was subtracted fran the O.D. for stimulated PMNs. 
For the iodination assay, opsonized zymosan was added to a 
sterile 12 X 75 tm test tube containing a balanced salt solution, 40 
nraoles NaT, 0.05 uCi and 2.5 X 10® PMNs to start the reaction. 
The tubes were capped and tumbled for 20 minutes at 37°C and the 
reaction stopped by the addition of cold 10% trichloroacetic acid 
(TCA). The results are expressed as the nananoles of iodide converted 
to a TCA-precipitable form/10^ PMNs/hour (18). 
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Data analysis 
All data are presented as % of control values; the control values 
are given in the footnotes of the tables and figures. Least 
significant difference was calculated to determine statistical 
significance for all assays evaluating the effects of tuftsin added to 
neutrophils in vitro. In the in vivo studies analysis of variance or 
regression was used to determine statistical significance. 
Results 
The in vitro effects of different concentrations of tuftsin on 
the iodination response of neutrophils from nontreated animals are 
shown in Fig. 1. The PMNs were incubated in tuftsin for 1 hour at 
37°C with constant shaking. Although it was found that many of the 
animals gave a positive response after a 20 minute incubation, the 
optimum time was found to be 1 hour. No difference was found when 
M199 was used as the incubation media nor vAien the cells were washed 
before being assayed (data not shown). Since 1.0 and 10.0 ug/ml gave 
the best response these concentrations were evaluated for their 
influence on other parameters of neutrophil function. 
The effects of tuftsin added in vitro on neutrophil randan 
migration, £. aureus ingestion, cytochrome C reduction, iodination and 
ADCC of PMNs from nontreated cattle are shown in Table 1. While 
ingestion, cytochrane C reduction, iodination and ADCC were increased 






Fig. 1. Effects of various concentrations of tuftsin on bovine 
neutrophil iodination. Control mean (jjSEM) = 41.6 
.8) onoles NaI/10 PMNs/hour. Points represent 
the means of 8 neutrophil preparations (+SEM)} *P<0.05 
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Table 1. In Vitro Effects of Tuftsin on Bovine Neutrophils 
Function 
Percent of Control Values® 
1.0 ug/ml 10.0 ug/ml 
Random Migration 100.0+5.2 96.9+4.9 
Staphylococcus aureus 
Ingestion 
Cytochrome C Reduction^ 
lodination*^ 
Antibody-dependent cell- . 










Control means (+ SEM) were 46.4 (+3.8) mm for random migration, 
30.6 (+5.4) % for S. aureus ingestion, 0.138 (jJ3.007) O.D. at 550nn 
for c^ochrome C reduction, 48.2 (+3.8) moles NaI/107pMNs/hour for 
iodination and 48.2 (+3.8) % 51cr release for ADCC. 
^n=6. 




responses were statistically significant. When tuftsin was added to 
PMNs from dexamethasone-treated animals no significant effect was 
observed on any of the functions tested (Table 2). 
The effects of tuftsin in vitro on neutrophils from 
nondexamethasone-treated animals was small and they were nonexistent 
on cells fran dexamethasone-treated animals. In order to determine if 
tuftsin would be more effective in vivo in altering neutrophil 
functions it was administered to both nontreated and dexamethasone-
treated cattle and the neutrophil functions evaluated. The in vivo 
effects of tuftsin (at different dosages) on neutrophils from normal 
animals are shown in Table 3. Analysis by linear regression indicated 
that the tuftsin had a statistically significant effect on the 
cytochrome C reduction, iodination and ADCC while the other functions 
were not significantly affected. In addition, a study using 3 
different concentrations of tuftsin administered with dexamethasone 
also indicated an improvement in the randan migration and ADCC 
responses at the 1.0 mg/animal dose although, in this particular 
experiment, the results were not statistically significant (Table 4). 
Our primary interest was in determining if tuftsin could effectively 
block any of the suppressive effects of glucocorticoids on 
neutrophils. Therefore, this experiment was repeated 3 times using a 
1.0 mg/animal dosage and evaluating all the neutrophil functions. 
The results are shown in Table 5. In these experiments 
dexamethasone treatment alone significantly suppressed iodination, 
ADCC, cytochrome C reduction and enhanced random migration. The 
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Table 2. In Vitro Effects of Tuftsin on Neutrophils from 
Dexamethasone-Treated Cattle 
Percent of Control Values® 




Cytochrome C Reduction 
lodination 
Antibody-dependent cell-









^Control means (+SEM) were 40.8 (+4.4) imi for random migration, 
10.3 (+1.2) % for S. aureus ingestion, 0.144 (jjO.005) O.D. at 550nm 
for c^ochrome C reduction, 27.9 (+2.0) nmoles Mal/lO^PMNs/hour for 
iodination and 27.9 (jM.4) % 51cr release for ADCC, n=6. 
Table 3. In vivo effects of various dosages of tuftsin on bovine neutrophil 
functions 
Function 0.01 (ip=5) 
Percent of Control Values 
dosage (rog/animal) 
0.1 (n=5) 1.0 (0=10) 3.3 (n=5) 10.0 (n^S) 
Random migration 102.7+^.5 99.5+8.6 92.3^.8 
Staphylococcus aureus 
Ingestion 120.9+7.1 89.9+5.5 101.4+5.7 
105.0+5.6 98.7+6.8 
94.8+14.1 103.5+9.9 
Cytochrome C Reduction 93.5+4.8 98.7+4.3 105.5+4.3 
lodination 109.0+6.7 104.3+8.2 102.0+5.5 




Control means (j^SEM) were 41.9 (+Ç..7) mm for random migration, 15.2 (^1.3) % 
for S. aureus ingestion, 0.245 (+0.010) O.D. at 550 nm for cytochroiifô C reduction, 
33.9(+7.7) moles NalA^ PMMs/hour for iodination and 47.2 (j^.8) %^^Cr release for 
ADOC. Regression analysis indicated that tuftsin had a statistically significant 
dose effect on cytochrome C reduction, iodination and ADOC (P<0.05). The n 
represents the number of animals / group. Each animal was bled on 3 consecutive 
days for evaluation of neutrophil function. 
Table 4. Effects of various dosages of tuftsin on neutrophil function in 
decatnethasone-treated cattle (0,04 mg/kg) 
Percent of Nontreated Control Values 
Function 0.0 
Tuftsin dosage (mg/animal) 
1.0 3.3 10.0 
Random migration 156.3+5.2 135.6+10.2 151.3+7.3 141.8+6.9 
Chemotaxis 82.3+3.1 87.4+5.0 84.8+3.4 91.3+3.5 
Iodination 42.7+2.0 40.2+2.2 44.0+2.4 41.7+1.8 
ADOC 75.3+10.1 86.3+9.5 78.5+10.0 69.5+10.3 
^Control means (+SEM) were 57.5 (+2.3) mm for random migration, 1.8 (jp.l) 
for chanotaxis 60.2 (+5.7) nmoles Nal/Id^EMNs/hour for iodination and 53.4 (j4.2) 
% 51cr release for ftDOC. There were 5 animals / grotp. Each animal was bled on 
3 consecutive days for evaluation of neutrojAiil function. No statistical 
significance was found. 
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Table 5. Effects of in vivo dexamethasone and dexamethasone-tufts in 
treatment on bovine neutrophils 
Functions 
Percent of Nontreated Control Values® 
Dexamethasone 
(0.04 mg/kg) 





S taphylococcus aureus 
Ingestion 
















Control means (+SEM) were 43.2 (+1.9) mm for random migration, 
2.8 (443.3) for chemotaxis, 27.1 (+1.4) % S. aureus ingestion, 0.218 
(+0.007) O.D. at 550nm for cytochrome C reduction, 44.3 (+2.9) nmoles 
NaI/10^ PMNs/hour for iodination and 52.5 (+2.4) % ^^Cr release for 
ADCC. Each group consisted of 15 animals. Each animal was bled on 3 
consecutive days for evaulation of neutrophil function. 
^P<0.01, compared to control values, 
°P<0.05, compared to dexamethasone-treated values. 
^P<0.05, compared to control values. 
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random migration of the tuftsin-dexamethasone-treated group was 
significantly reduced frcm that of the dexamethasone group and the 
iodination response was significantly increased although the 
difference is small. While the ADCC was somewhat higher in the 
tuftsin-dexamethasone group than the dexamethasone alone group, the 
difference was not significant. 
Discussion 
The effects of tuftsin were found to vary depending on whether it 
was added in vitro to neutrofdiils from normal or dexamethasone-treated 
cattle or whether it was administered to cattle alone or in 
conjunction with dexamethasone. When neutrophils from normal cattle 
were treated in vitro, there was a significant enhancement of 
neutrophil ingestion and iodination. While both the ADCC and 
cytochrome C reduction responses were increased the differences were 
not statistically significant. It was observed that increasing the 
concentration of tuftsin in the iodination assay would diminish the 
response. This phenomena has been previously reported in other 
experiments (20,21). Tritsch and Niswander (20) found that lower 
concentrations of tuftsin (125 nM) were more effective than higher 
concentrations (500 nM) in stimulating superoxide anion production; 
while Catane et al. (21) found that the anti-neoplastic activity of 
tuftsin in mice was much better at 0.5 mg/kg of body weight than 25 
mg/kg. It has been suggested that this phenomenon is due to a self-
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regulation by,tuftsin (3). When given in concentrations above that 
required for optimum receptor occupancy the excess tetrapeptide may be 
degraded to a tripeptide by an aminopeptidase enzyme present on the 
neutrophil membrane. This tripeptide, lys-pro-arg, has been shown to 
block the effects of tuftsin (5). When tuftsin alone was given in 
vivo at a variety of dosages, linear regression analysis indicated the 
tuftsin significantly altered ADCC, iodination and cytochrome C 
reduction by bovine neutrophils. 
Dexamethasone treatment resulted in the suppression of neutrophil 
iodination, ADCC, cytochrome C reduction and an enhancement in randan 
migration. In vitro tuftsin treatmoit of neutrophils from 
dexamethasone-treated animals did not alter any of these functions. 
However, when tuftsin was given in vivo in conjunction with 
dexamethasone both the random migration and iodination responses were 
significantly altered. The increase in iodination of the tuftsin-
dexamethasone group over that of the dexamethasone group was not very 
dramatic, but the effects on random migration were larger and more 
consistent. 
It is interesting that the function most affected by tuftsin in 
dexamethasone-treated cattle is not significantly altered under any of 
the other conditions (in vitro on neutrophils from normal or 
dexamethasone-treated cattle, or on neutrophils from tuftsin-treated 
normal cattle). These results suggest that tuftsin may be working 
through different cell types in vitro and in vivo. The in vitro 
effects of tuftsin on normal bovine neutrophils is probably mediated 
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by a direct effect on the neutrophils. Prior in vivo dexamethasone 
treatanent blocked any of the direct effects of tuftsin on neutrophils. 
In vivo administration ajçeared not to affect neutrophils in the 
same manner as in vitro treatment. It is not clear if the in vivo 
action of tuftsin is mediated through other cell types. It is known 
that dexamethasone alters several neutrophil functions and that at 
least two of these functions, random migration and ADOC, are altered 
indirectly by factors secreted by monocytes (11). Therefore the 
ability of tuftsin in vivo to overcome the effects of dexamethasone on 
random migration may be the result of tuftsin interacting with 
monocytes to help prevent the effects of dexamethasone on these cells. 
Florentin et al. (22) came to a similar conclusion after 
examining the effects of tuftsin on a number of immune functions 
(antibody and mitogenic responses, ILt2 production, cytostatic 
activity on tumor cells) in vivo in mice. Because they had observed 
effects up to 14 days after administration, they suggested that 
tuftsin may be triggering a number of cell to cell interactions in 
vivo and that all of the effects observed in vivo may be mediated 
primarily by macrophages. In addition, Florentin et al. (22) and 
Bruley-Rosset (Z3} have determined that different responses to tuftsin 
may be obtained depending on the "physiopathological state" of the 
neutrophils. Inflammatory, or elicited PMNs may respond in an 
opposite way to normal PMNs in their chemotactic response to tuftsin. 
Aged mice do not respond the same as young mice to in vivo treatment 
with tuftsin with regard to NK cell and T-cell cytotoxicity. 
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These findings are consistent with our results in that tuftsin 
treatment appears to affect different parameters of neutrophil 
function under different circumstances (in vivo verses in vitro, 
dexamethasone treatment verses no dexamethasone treatment). These 
findings may, in part, explain some of the discrepancies found in the 
literature with regard to the effects of tuftsin on various cell 
types. Tuftsin has been shown to enhance cytotoxicity, alter randan 
migration and chenotactic responses, enhance phagocytosis and to 
stimulate oxidative metabolism in neutrophils and macrophages (1,2,3). 
However, a number of labs have reported no effects or suppressive 
effects v^en using the peptide (6,24,25,26). Sane have attributed 
this to suppressive impurities sometimes found in canmercial 
preparations (27). While this may be true, the literature and our own 
findings have lead us to believe that one must consider a nunber of 
factors such as dosage used and state of health of the animal in vivo 
and concentration in vitro to accurately compare the results found in 
different labs. 
There were two reports found in the literature regarding the in 
vitro effects of tuftsin on bovine neutrophils. In one, tuftsin (at 
2uM concentration) was found to slightly increase HgOg production by 
resting bovine neutrophils and slightly suitress HgOg production in 
opsonized zymosan stimulated neutrophils, however no statistical 
significance was found (25). In another report, Erp and Fahrney (28) 
fractionated bovine gamnaglobulin into 4 fractions and found that 80% 
of a phagocytosis stimulating factor (normally present in the serum) 
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was recovered in fraction IV. Although they found that the addition 
of tuftsin in vitro did stimulate bovine BMN phagocytosis, on a molar 
basis the tuftsin was only 10% as active as the g^agocytosis 
stimulating factor. In addition, trypsin treatment did not liberate a 
stimulatory peptide from fraction IV, as would be expected if tuftsin 
was responsible for the activity. They concluded that the factor 
responsible for the increased E*iagocytic activity must differ 
structurally from tuftsin. 
As mentioned previously, our primary interest was in determining 
the effectiveness of tuftsin in overcoming the effects of 
glucocorticoids on bovine neutrophils. The results indicate that one 
function in particular, random migration, is consistently altered by 
tuftsin in dexamethasone-treated cattle. Dexamethasone dramatically 
enhances the random migration of bovine neutrophils and this change 
may indicate a decrease in the cells ability to adhere to vascular 
endothelium and migrate into the tissue in response to 
chanoattractants. Tuftsin treatment significantly reduced the amount 
of randan migration of neutrophils from dexamethasone-treated cells 
but did not return it completely to control values. Tuftsin also 
significantly altered the suppression of neutrophil iodination 
although the difference is rather small. Since random migration is 
not altered by in vitro treatment with tuftsin this effect may be 
indirectly mediated on the neutrophils. The dosage used in these 
studies was 1.0 mg/animal; while most in vivo studies use much higher 
dosages (in terms of body weight). Table 3 indicates that the 
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cytochrome C reduction was steadily increasing with increasing amounts 
of tuftsin. It may be that a higher in vivo dosage of tuftsin would 
show effects on the other neutrof^il functions as well. 
In conclusion, tuftsin treatment was able to alter a nunnber of 
neutrophil functions. Different functions were affected under 
different treatment conditions. In vitro tuftsin treatment on normal 
bovine neutrophils increased iodination and ingestion. However, when 
tuftsin was added in vitro to neutrophils from dexamethasone-treated 
animals, no effect was observed on any of the functions. In vivo 
treatment of normal cattle significantly altered cytochrome C 
reduction. However vAen dexamethasone and tuftsin were both given, 
tuftsin treatment significantly altered the effects of dexamethasone 
on neutrophil randan migration and iodination. Because of its ability 
to overcome some of these effects, tuftsin may be useful as part of an 
immunomodulating therapy designed to prevent immunosuppression by 
glucocorticoids. 
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GENERAL SUMMARY 
It has previously been established that in vivo dexamethasone 
treatment of cattle results in suppression of neutrophil iodination, 
antibody-dependent cell-mediated cytotoxicity (ADOC), oxidative 
metabolism and an increase in random migration. The first part of 
this study addressed the relationship between alteration of these 
functions and the arachidonic acid metabolian of neutrophils from 
dexamethasone-treated animals. 
Neutrophils stimulated with opsonized zymosan released 
arachidonic acid from the phospholipids and formed the lipoxygenase 
products leukotriene (LTB^) and 5-hydroxyeicosatetraenoic acid (5-
HETE). Neutrophils from dexamethasone-treated cattle released 
significantly less arachidonic acid and consequently produced less 
LTB^ and 5-HETE. To determine how this might relate to neutrophil 
function, neutrophils from normal animals were treated with the 
lipoxygenase inhibitors nordihydroguaiaretic acid (NDGA) and BtV755c 
and the functions evaluated. The inhibitors were used at various 
concentrations and in addition, a cyclooxygenase inhibitor, 
indomethacin, was also used. 
The lipoxygenase inhibitors suppressed iodination and cytochrome 
C reduction in a titratable manner but had no significant effect on 
neutrophil ADOC, random migration or Staphylococcus aureus ingestion, 
Indomethacin had no effect on any of the functions. These compounds 
were also tested for their effects on bovine neutrophil arachidonic 
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acid metabolism. Both NDGA and BW755c suppressed arachidonic acid 
metabolism while indcmethacin had no effect. 
It was concluded that in vivo dexamethasone treatment results in 
the suppression of bovine neutrophil arachidonic acid metabolism which 
could account for the changes in neutrophil iodination and cytochrome 
C reduction in dexamethasone-treated animals but not ADCC or random 
migration. These findings support the idea that glucocorticoids act 
to suppress neutrophil functions by at least two separate mechanisms, 
one of vAiich is possibly suppression of arachidonic acid metabolism. 
The second part of this study involved the use of the 
immunomodulator tuftsin on bovine neutrophils under a variety of 
conditions. The aim of this study was to determine if tuftsin could 
be used therapeutically to prevent the suppressive effects of 
glucocorticoids on neutrophils. When added in vitro to normal 
neutrophils tuftsin enhanced neutrophil ingestion and iodination. 
NeutrogAiils from dexamethasone-treated cattle showed no response to 
tuftsin in vitro. 
Tuftsin was also administered in vivo to cattle at several 
different dosages and the neutrophil functions evaluated. A 
significant change in neutrophil cytochrome C reduction, iodination 
and ADCC were found. When tuftsin was administered in conjunction 
with dexamethasone it was found to significantly alter the 
dexamethasone effect on neutrophil random migration and iodination. 
In addition, the ADCC response was enhanced although not 
significantly. Since in vitro studies revealed no effect of tuftsin 
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on random migration, it was concluded that tuftsin may be acting 
indirectly in in vivo situations to alter the neutrophil random 
migration response. These results indicate that tuftsin may be 
as part of an immunomodulating therapy designed to prevent the 
suppressive effects of glucocorticoids. 
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